Publication | Closed Access

A Randomized Trial of Sodium Fluoride (60 mg) Estrogen in Postmenopausal Osteoporotic Vertebral Fractures: Increased Vertebral Fractures and Peripheral Bone Loss with Sodium Fluoride; Concurrent Estrogen Prevents Peripheral Loss, But Not Vertebral Fractures

Skeletal TraumaBone HealthPeripheral Bone LossGynecologyOsteoporosisSodium FluorideRandomized TrialMedicineOrthopaedic SurgeryWomen's Health